Stay updated on SAR422459 in Stargardt's Macular Degeneration Clinical Trial
Sign up to get notified when there's something new on the SAR422459 in Stargardt's Macular Degeneration Clinical Trial page.

Latest updates to the SAR422459 in Stargardt's Macular Degeneration Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check17 days agoChange DetectedPage revision tag updated to v3.4.3.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedAdded site Revision: v3.4.2 and removed older Revision: v3.4.1 along with a government-funding operating-status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedA site-wide notice about government funding and operating status was added, with links to cc.nih.gov and opm.gov for updates. The site version was updated to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check60 days agoChange DetectedAdded a glossary toggle and minor wording edits to labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data') and updated the revision tag from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check74 days agoChange DetectedRevision: v3.3.4 is shown on the page, replacing the previous v3.3.3. There are no apparent changes to core trial details like objectives, eligibility criteria, or outcomes.SummaryDifference0.1%

Stay in the know with updates to SAR422459 in Stargardt's Macular Degeneration Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR422459 in Stargardt's Macular Degeneration Clinical Trial page.